Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study

BACKGROUND: Face mask is the first line to protect the respiratory mucosa from the coronavirus particles in aerocells and droplets and without this, the exposure of the mucosa to the virus and allergens trigger the immune and inflammatory system. These lead to Allergic Rhinitis (AR) symptoms or viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmaeilzadeh, Hossein, Goodarzian, MReza, Abbasi, Alireza, Alamdari, Mohammad, Mortazavi, Negar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113883/
https://www.ncbi.nlm.nih.gov/pubmed/37091360
http://dx.doi.org/10.1002/hsr2.1226
_version_ 1785027918056914944
author Esmaeilzadeh, Hossein
Goodarzian, MReza
Abbasi, Alireza
Alamdari, Mohammad
Mortazavi, Negar
author_facet Esmaeilzadeh, Hossein
Goodarzian, MReza
Abbasi, Alireza
Alamdari, Mohammad
Mortazavi, Negar
author_sort Esmaeilzadeh, Hossein
collection PubMed
description BACKGROUND: Face mask is the first line to protect the respiratory mucosa from the coronavirus particles in aerocells and droplets and without this, the exposure of the mucosa to the virus and allergens trigger the immune and inflammatory system. These lead to Allergic Rhinitis (AR) symptoms or virus infection. AIM: This study discusses about the effects of face mask on the severity of AR symptoms using the Sino‐Nasal Outcome Test (SNOT‐22) in AR cases during the Corona Virus Disease 2019 (COVID‐19) pandemic. METHOD: In this cross‐sectional study, 54 cases previously diagnosed as moderate and severe AR based on Allergic Rhinitis and its Impact on Asthma and Visual Analog Scale score referred to the tertiary allergy clinic were involved, while 5 of them were excluded. AR symptoms before and during the pandemic were compared based on the SNOT‐22 questionnaire. Demographics, AR severity, and comorbidities were registered. RESULTS: The mean age was 31.4 ± 13.5 years with the male−female ratio of 1.4. The mean SNOT‐22 score was 36.1 ± 20.3 before and 29.5 ± 16.8 during the pandemic. Although 36.7% (n: 18) of all participants had severe symptoms before the pandemic, 10.2% (n: 5) had severe AR symptoms during the pandemic. 53.0% (n: 26) of patients had moderate AR symptoms, and 36.7% (n: 18) had mild AR symptoms in the pandemic. There was no significant difference between each paired subgroup in AR symptom changes but the symptom improvement was significant in most of the subgroups when compared to the pre‐pandemic period. Smoking had an adverse effect on AR symptoms (p: 0.034). CONCLUSION: Face mask affects the quality of life in AR patients and improves the severity of AR symptoms during COVID‐19 pandemic. Smoking worsens this severity. Age, gender, pet ownership, underlying conditions, and previous COVID‐19 infection were not associated with AR symptoms severity and alteration in the AR individuals' quality of life during the COVID‐19 pandemic.
format Online
Article
Text
id pubmed-10113883
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101138832023-04-20 Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study Esmaeilzadeh, Hossein Goodarzian, MReza Abbasi, Alireza Alamdari, Mohammad Mortazavi, Negar Health Sci Rep Original Research BACKGROUND: Face mask is the first line to protect the respiratory mucosa from the coronavirus particles in aerocells and droplets and without this, the exposure of the mucosa to the virus and allergens trigger the immune and inflammatory system. These lead to Allergic Rhinitis (AR) symptoms or virus infection. AIM: This study discusses about the effects of face mask on the severity of AR symptoms using the Sino‐Nasal Outcome Test (SNOT‐22) in AR cases during the Corona Virus Disease 2019 (COVID‐19) pandemic. METHOD: In this cross‐sectional study, 54 cases previously diagnosed as moderate and severe AR based on Allergic Rhinitis and its Impact on Asthma and Visual Analog Scale score referred to the tertiary allergy clinic were involved, while 5 of them were excluded. AR symptoms before and during the pandemic were compared based on the SNOT‐22 questionnaire. Demographics, AR severity, and comorbidities were registered. RESULTS: The mean age was 31.4 ± 13.5 years with the male−female ratio of 1.4. The mean SNOT‐22 score was 36.1 ± 20.3 before and 29.5 ± 16.8 during the pandemic. Although 36.7% (n: 18) of all participants had severe symptoms before the pandemic, 10.2% (n: 5) had severe AR symptoms during the pandemic. 53.0% (n: 26) of patients had moderate AR symptoms, and 36.7% (n: 18) had mild AR symptoms in the pandemic. There was no significant difference between each paired subgroup in AR symptom changes but the symptom improvement was significant in most of the subgroups when compared to the pre‐pandemic period. Smoking had an adverse effect on AR symptoms (p: 0.034). CONCLUSION: Face mask affects the quality of life in AR patients and improves the severity of AR symptoms during COVID‐19 pandemic. Smoking worsens this severity. Age, gender, pet ownership, underlying conditions, and previous COVID‐19 infection were not associated with AR symptoms severity and alteration in the AR individuals' quality of life during the COVID‐19 pandemic. John Wiley and Sons Inc. 2023-04-19 /pmc/articles/PMC10113883/ /pubmed/37091360 http://dx.doi.org/10.1002/hsr2.1226 Text en © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Esmaeilzadeh, Hossein
Goodarzian, MReza
Abbasi, Alireza
Alamdari, Mohammad
Mortazavi, Negar
Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title_full Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title_fullStr Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title_full_unstemmed Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title_short Face mask correlation with allergic rhinitis symptoms severity during COVID‐19 pandemic: A cross‐sectional study
title_sort face mask correlation with allergic rhinitis symptoms severity during covid‐19 pandemic: a cross‐sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113883/
https://www.ncbi.nlm.nih.gov/pubmed/37091360
http://dx.doi.org/10.1002/hsr2.1226
work_keys_str_mv AT esmaeilzadehhossein facemaskcorrelationwithallergicrhinitissymptomsseverityduringcovid19pandemicacrosssectionalstudy
AT goodarzianmreza facemaskcorrelationwithallergicrhinitissymptomsseverityduringcovid19pandemicacrosssectionalstudy
AT abbasialireza facemaskcorrelationwithallergicrhinitissymptomsseverityduringcovid19pandemicacrosssectionalstudy
AT alamdarimohammad facemaskcorrelationwithallergicrhinitissymptomsseverityduringcovid19pandemicacrosssectionalstudy
AT mortazavinegar facemaskcorrelationwithallergicrhinitissymptomsseverityduringcovid19pandemicacrosssectionalstudy